CSIMarket
 


Rocket Pharmaceuticals Inc   (RCKT)
Other Ticker:  
 
 

RCKT's Operating Income Growth by Quarter and Year

Rocket Pharmaceuticals Inc 's Operating Income results by quarter and year




RCKT Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -44.33 -27.39 -19.17
III Quarter September -58.49 -49.65 -23.56 -18.39
II Quarter June -54.21 -34.05 -24.12 -18.95
I Quarter March -42.56 -39.22 -19.65 -26.55
FY   -155.26 -167.25 -94.72 -83.06



RCKT Operating Income third quarter 2022 Y/Y Growth Comment
Rocket Pharmaceuticals Inc in the third quarter 2022 recorded Operating Loss of $ -58.49 millions.

According to the results reported in the third quarter 2022, Rocket Pharmaceuticals Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Rocket Pharmaceuticals Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


RCKT Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Rocket Pharmaceuticals Inc 's third quarter 2022 Operating Income $ -58.49 millions RCKT's Income Statement
Rocket Pharmaceuticals Inc 's third quarter 2021 Operating Income $ -49.65 millions Quarterly RCKT's Income Statement
New: More RCKT's historic Operating Income Growth >>


RCKT Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Rocket Pharmaceuticals Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RCKT's III. Quarter Q/Q Operating Income Comment
III. Quarter 2022 results of -58.49 millions by Rocket Pharmaceuticals Inc come out even less good if you take a look at Operating Loss -54.21 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Rocket Pharmaceuticals Inc achieved highest sequential Operating Income growth. While Rocket Pharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RCKT's III. Quarter Q/Q Operating Income Comment
Recent results of -58.49 millions by Rocket Pharmaceuticals Inc appear even worse considering the Operating Loss -54.21 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Rocket Pharmaceuticals Inc achieved highest sequential Operating Income growth. While Rocket Pharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is .


Rocket Pharmaceuticals Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Operating Income 12 Months Ending $ -199.59 $ -190.75 $ -170.59 $ -167.25 $ -150.30
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Rocket Pharmaceuticals Inc ' has realized cumulative trailing twelve months Operating Loss of $ -200 millions in the Sep 30 2022 period.
The results are detiriorating as the cumulative Operating Loss is inflating from $ -190.75 millions in TTM ending quarter Jun 30 2022 and $ -54.21 millions for the twelve months ending in the quarter Sep 30 2021.

Rocket Pharmaceuticals Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Rocket Pharmaceuticals Inc ' has realized cumulative trailing twelve months Operating Loss of $ -200 millions in the Sep 30 2022 period.
The situation is getting worse as the cumulative Operating Loss is inflating from $ -190.75 millions in the twelve months ending a quarter before and $ -54.21 millions for the twelve months ending in the quarter a year ago.

Rocket Pharmaceuticals Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
RCKT's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for RCKT's Competitors
Operating Income Growth for Rocket Pharmaceuticals Inc 's Suppliers
Operating Income Growth for RCKT's Customers

You may also want to know
RCKT's Annual Growth Rates RCKT's Profitability Ratios RCKT's Asset Turnover Ratio RCKT's Dividend Growth
RCKT's Roe RCKT's Valuation Ratios RCKT's Financial Strength Ratios RCKT's Dividend Payout Ratio
RCKT's Roa RCKT's Inventory Turnover Ratio RCKT's Growth Rates RCKT's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2022
Dexcom Inc 24.68%$ 24.683 millions
Progyny Inc 24.16%$ 24.159 millions
Bristol myers Squibb Company18.36%$ 18.364 millions
Merit Medical Systems Inc17.11%$ 17.111 millions
Repligen Corp16.53%$ 16.531 millions
Surgery Partners Inc 16.51%$ 16.509 millions
Avantor Inc 16.27%$ 16.273 millions
Bruker Corporation15.99%$ 15.989 millions
Integra Lifesciences Holdings Corp15.26%$ 15.255 millions
Option Care Health Inc 14.82%$ 14.816 millions
Zimmer Biomet Holdings Inc 14.15%$ 14.146 millions
Acadia Healthcare Company Inc 13.82%$ 13.821 millions
Sonida Senior Living Inc 13.67%$ 13.667 millions
Ensign Group Inc12.02%$ 12.016 millions
Globus Medical Inc 11.95%$ 11.950 millions
Mettler Toledo International Inc10.44%$ 10.436 millions
Halozyme Therapeutics Inc 10.20%$ 10.195 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NDSN's Profile

Stock Price

NDSN's Financials

Business Description

Fundamentals

Charts & Quotes

NDSN's News

Suppliers

NDSN's Competitors

Customers & Markets

Economic Indicators

NDSN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071